Marc A. Rodwin, J.D.,Ph.D
Suffolk University
H-index: 29
North America-United States
Top articles of Marc A. Rodwin, J.D.,Ph.D
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
How Will Medicare Negotiate Drug Prices, And What Impact Will It Have? | Health Affairs Forefront | Marc A Rodwin John D Lantos | 2024 |
The FDA’s Dueling Narratives: Protector Versus Obstacle | Health Affairs Forefront | John D Lantos Marc A Rodwin | 2023 |
The No Surprises Act: A Conservative Band-Aid to Protect Business as Usual | International Journal of Social Determinants of Health and Health Services | Marc A Rodwin Alan Sager | 2023/1 |
WHO’s Attempt to Navigate Commercial Influence and Conflicts of Interest in Nutrition Programs While Engaging With Non-State Actors: Reflections on WHO Guidance for Nation … | International Journal of Health Policy and Management | Marc A Rodwin | 2022/3 |
German Pharmaceutical pricing: lessons for the United States | International Journal of Health Services | Marc A Rodwin Sara Gerke | 2022/1 |
Assessing US Pharmaceutical Policy and Pricing Reform Legislation in Light of European Price and Cost Control Strategies | Journal of Health Politics, Policy and Law | Marc A Rodwin | 2022/12/1 |
Common pharmaceutical price and cost controls in the United Kingdom, France, and Germany: lessons for the United States | International Journal of Health Services | Marc A Rodwin | 2021/7 |
How the United Kingdom controls pharmaceutical prices and spending: learning from its experience | International journal of health services | Marc A Rodwin | 2021/4 |
The use of ‘added benefit’to determine the price of new anti-cancer drugs in France, 2004–2017 | European Journal of Cancer | Marc A Rodwin Julien Mancini Ségolène Duran Anne-Céline Jalbert Patrice Viens | 2021/3/1 |
Drug Pricing, Competition, And Regulation/Reply | Health Affairs | Marc A Rodwin James C Robinson Quentin Jarrion | 2021/11/1 |
Prices of cancer drugs increase in France despite little added benefit | PharmacoEconomics & Outcomes News | MA Rodwin | 2021/1 |
Causes and cures | Conflict of Interest and Medicine: Knowledge, Practices, and Mobilizations | Marc André Rodwin | 2021/9/6 |
Conflicts of interest in medical practice: Causes and cures | Marc André Rodwin | 2021/9/5 | |
Pharmaceutical price and spending controls in France: lessons for the United States | International Journal of Health Services | Marc A Rodwin | 2020/4 |
Average international market pricing for us pharmaceuticals—lessons from Europe | Health Affairs Forefront | Marc A Rodwin | 2020 |
